MDisrupt is an Austin, TX–based marketplace serving the health tech and life sciences industries. Its AI-powered Health Expert Marketplace connects companies with over 2,500 professionals, including clinicians, health system executives, and payor leaders. The platform streamlines access to essential expertise to enable rapid product development and validation. The company raised $1M in funding led by American Heart Association Ventures, and Lisa Suennen joined the MDisrupt board. MDisrupt says it will use the funds to support expanded adoption of its AI-powered marketplace and to add new features through a strategic collaboration with the Association to meet members' needs. The company is led by CEO and founder Ruby Gadelrab. MDisrupt is a marketplace that connects healthtech and life science companies with health experts to help build, commercialize and scale health products. Led by founder and CEO Ruby Gadelrab and based in Austin, TX, the company reports a network of over 1,500 experts from organizations including Blue Cross Blue Shield, CVS, Willis Towers Watson, the U.S. FDA, Optum, and Cleveland Clinic. MDisrupt serves both startups and enterprise customers across healthtech and life science sectors. The company raised $3M in Seed funding and intends to use the capital to launch its platform and expand its client roster. In conjunction with the round, Cat Middleton of The Venture Collective is joining the MDisrupt board of directors. MDisrupt is transforming into a digital health intelligence company that organizes the world's digital health products by performance through clinically crowdsourced data generation. Founded in 2019 and based in Austin, Texas, it connects digital health companies with health industry experts and has helped more than 55 companies build and scale products. The company's platform combines three elements—people, platform, and data—to digitize solutions for access to experts on demand, clinical early adopters, and real-world performance data. MDisrupt plans to expand the platform to enable innovators to rapidly generate the real-world performance data needed to commercialize and scale their products and to serve as a marketplace and benchmark for the industry. The platform's objective dataset, built on real-world clinical performance from every digital health product on the platform, will feed its digital health intelligence engine. The company says the output will influence key decision-makers and provide standards and benchmarks for the growing digital health sector.

Total raised

$10M

Funding rounds

3

Latest round

Equity

Latest activity

Oct 2024